THE DEAL, AT A GLANCE
From the announcementBiofourmis
01Who is involvedBacked by General AtlanticFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedBiofourmis raised $300M Series DFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersBiofourmis is applying AI-powered remote patient monitoring and analytics to hospital-at-home and post-surgical monitoring use cases where earlier deterioration…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Biofourmis · Financing Record
Explore source-linked visual explanations for Biofourmis. Unsupported claims are withheld while source review continues.
Record 1524 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →